A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FOTORAN, Wesley L. et al. Establishment of an antiplasmodial vaccine based on PfRH5-Encoding RNA replicons stabilized by cationic liposomes. Pharmaceutics, v. 15, n. 4, p. 1-17, 2023Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics15041223. Acesso em: 29 maio 2024.
APA
Fotoran, W. L., Silva, J. R. da, Glitz, C., Ferreira, L. C. de S., & Wunderlich, G. (2023). Establishment of an antiplasmodial vaccine based on PfRH5-Encoding RNA replicons stabilized by cationic liposomes. Pharmaceutics, 15( 4), 1-17. doi:10.3390/pharmaceutics15041223
NLM
Fotoran WL, Silva JR da, Glitz C, Ferreira LC de S, Wunderlich G. Establishment of an antiplasmodial vaccine based on PfRH5-Encoding RNA replicons stabilized by cationic liposomes [Internet]. Pharmaceutics. 2023 ; 15( 4): 1-17.[citado 2024 maio 29 ] Available from: https://doi.org/10.3390/pharmaceutics15041223
Vancouver
Fotoran WL, Silva JR da, Glitz C, Ferreira LC de S, Wunderlich G. Establishment of an antiplasmodial vaccine based on PfRH5-Encoding RNA replicons stabilized by cationic liposomes [Internet]. Pharmaceutics. 2023 ; 15( 4): 1-17.[citado 2024 maio 29 ] Available from: https://doi.org/10.3390/pharmaceutics15041223
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUNARDELLI, Victória Alves Santos et al. Diagnostic and vaccine potential of Zika virus envelope protein (E) derivates produced in bacterial and insect cells. Frontiers in Immunology, v. 14, p. 1-14, 2023Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2023.1071041. Acesso em: 29 maio 2024.
APA
Lunardelli, V. A. S., Almeida, B. da S., Apostolico, J. de S., Rezende, T., Yamamoto, M. M., Pereira, S. S., et al. (2023). Diagnostic and vaccine potential of Zika virus envelope protein (E) derivates produced in bacterial and insect cells. Frontiers in Immunology, 14, 1-14. doi:10.3389/fimmu.2023.1071041
NLM
Lunardelli VAS, Almeida B da S, Apostolico J de S, Rezende T, Yamamoto MM, Pereira SS, Bueno MFC, Pereira LR, Karina Inacio Carvalho, Slhessarenko RD, Rosa DS, Ferreira LC de S, Boscardin SB. Diagnostic and vaccine potential of Zika virus envelope protein (E) derivates produced in bacterial and insect cells [Internet]. Frontiers in Immunology. 2023 ; 14 1-14.[citado 2024 maio 29 ] Available from: https://doi.org/10.3389/fimmu.2023.1071041
Vancouver
Lunardelli VAS, Almeida B da S, Apostolico J de S, Rezende T, Yamamoto MM, Pereira SS, Bueno MFC, Pereira LR, Karina Inacio Carvalho, Slhessarenko RD, Rosa DS, Ferreira LC de S, Boscardin SB. Diagnostic and vaccine potential of Zika virus envelope protein (E) derivates produced in bacterial and insect cells [Internet]. Frontiers in Immunology. 2023 ; 14 1-14.[citado 2024 maio 29 ] Available from: https://doi.org/10.3389/fimmu.2023.1071041
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JESUS, Monica Josiane Rodrigues de et al. Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation. Nanomedicine: Nanotechnology, Biology and Medicine, v. 45, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.nano.2022.102595. Acesso em: 29 maio 2024.
APA
Jesus, M. J. R. de, Favaro, M. T. de P., Carvalho, A. A. V. B., Amarante, M. F. de C., Almeida, B. da S., Silva, M. de O., et al. (2022). Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation. Nanomedicine: Nanotechnology, Biology and Medicine, 45, 1-11. doi:10.1016/j.nano.2022.102595
NLM
Jesus MJR de, Favaro MT de P, Carvalho AAVB, Amarante MF de C, Almeida B da S, Silva M de O, Santos RA, Barbosa CG, Brito SCM, Freitas Junior LHG de, Boscardin SB, Ferreira LC de S. Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation [Internet]. Nanomedicine: Nanotechnology, Biology and Medicine. 2022 ; 45 1-11.[citado 2024 maio 29 ] Available from: https://doi.org/10.1016/j.nano.2022.102595
Vancouver
Jesus MJR de, Favaro MT de P, Carvalho AAVB, Amarante MF de C, Almeida B da S, Silva M de O, Santos RA, Barbosa CG, Brito SCM, Freitas Junior LHG de, Boscardin SB, Ferreira LC de S. Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation [Internet]. Nanomedicine: Nanotechnology, Biology and Medicine. 2022 ; 45 1-11.[citado 2024 maio 29 ] Available from: https://doi.org/10.1016/j.nano.2022.102595
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Robert Andreata et al. Validation of serological methods for COVID-19 and retrospective screening of health employees and visitors to the São Paulo University Hospital, Brazil. Frontiers in Cellular and Infection Microbiology, v. 12, p. 1-8, 2022Tradução . . Disponível em: https://doi.org/10.3389/fcimb.2022.787411. Acesso em: 29 maio 2024.
APA
Santos, R. A., Machado, R. R. G., Alves, R. P. dos S., Sales, N. S., Soares, C. P., Rodrigues, K. B., et al. (2022). Validation of serological methods for COVID-19 and retrospective screening of health employees and visitors to the São Paulo University Hospital, Brazil. Frontiers in Cellular and Infection Microbiology, 12, 1-8. doi:10.3389/fcimb.2022.787411
NLM
Santos RA, Machado RRG, Alves RP dos S, Sales NS, Soares CP, Rodrigues KB, Andrade JB, Fock RA, Margarido PFR, Carvalho CRG, Boscardin SB, Durigon EL, Ferreira LC de S. Validation of serological methods for COVID-19 and retrospective screening of health employees and visitors to the São Paulo University Hospital, Brazil [Internet]. Frontiers in Cellular and Infection Microbiology. 2022 ; 12 1-8.[citado 2024 maio 29 ] Available from: https://doi.org/10.3389/fcimb.2022.787411
Vancouver
Santos RA, Machado RRG, Alves RP dos S, Sales NS, Soares CP, Rodrigues KB, Andrade JB, Fock RA, Margarido PFR, Carvalho CRG, Boscardin SB, Durigon EL, Ferreira LC de S. Validation of serological methods for COVID-19 and retrospective screening of health employees and visitors to the São Paulo University Hospital, Brazil [Internet]. Frontiers in Cellular and Infection Microbiology. 2022 ; 12 1-8.[citado 2024 maio 29 ] Available from: https://doi.org/10.3389/fcimb.2022.787411
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FLÓREZ-ÁLVAREZ, Lizdany et al. Hemorrhagic fever viruses: pathogenesis, therapeutics, and emerging and re-emerging potential. Frontiers in Microbiology, v. 13, p. 1-16, 2022Tradução . . Disponível em: https://doi.org/10.3389/fmicb.2022.1040093. Acesso em: 29 maio 2024.
APA
Flórez-Álvarez, L., Souza, E. E. de, Botosso, V. F., Oliveira, D. B. L. de, Ho, P. L., Taborda, C. P., et al. (2022). Hemorrhagic fever viruses: pathogenesis, therapeutics, and emerging and re-emerging potential. Frontiers in Microbiology, 13, 1-16. doi:10.3389/fmicb.2022.1040093
NLM
Flórez-Álvarez L, Souza EE de, Botosso VF, Oliveira DBL de, Ho PL, Taborda CP, Palmisano G, Capurro M de L, Pinho JRR, Ferreira HL, Minoprio PMC, Arruda E, Ferreira LC de S, Wrenger C, Durigon EL. Hemorrhagic fever viruses: pathogenesis, therapeutics, and emerging and re-emerging potential [Internet]. Frontiers in Microbiology. 2022 ; 13 1-16.[citado 2024 maio 29 ] Available from: https://doi.org/10.3389/fmicb.2022.1040093
Vancouver
Flórez-Álvarez L, Souza EE de, Botosso VF, Oliveira DBL de, Ho PL, Taborda CP, Palmisano G, Capurro M de L, Pinho JRR, Ferreira HL, Minoprio PMC, Arruda E, Ferreira LC de S, Wrenger C, Durigon EL. Hemorrhagic fever viruses: pathogenesis, therapeutics, and emerging and re-emerging potential [Internet]. Frontiers in Microbiology. 2022 ; 13 1-16.[citado 2024 maio 29 ] Available from: https://doi.org/10.3389/fmicb.2022.1040093
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, Aléxia Adrianne Venceslau et al. Nano-multilamellar lipid vesicles loaded with a recombinant form of the chikungunya virus E2 protein improve the induction of virus-neutralizing antibodies. Nanomedicine: Nanotechnology, Biology and Medicine, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.nano.2021.102445. Acesso em: 29 maio 2024.
APA
Carvalho, A. A. V., Favaro, M. T. de P., Pereira, L. R., Jesus, M. J. R., Pereira, S. S., Santos, R. A., et al. (2021). Nano-multilamellar lipid vesicles loaded with a recombinant form of the chikungunya virus E2 protein improve the induction of virus-neutralizing antibodies. Nanomedicine: Nanotechnology, Biology and Medicine. doi:10.1016/j.nano.2021.102445
NLM
Carvalho AAV, Favaro MT de P, Pereira LR, Jesus MJR, Pereira SS, Santos RA, Alves RP dos S, Amarante MFC, Rodrigues KB, Silva JR da, Machado RRG, Cunha M dos P, Zanotto PM de A, Fotoran WL, Wunderlich G, Durigon EL, Ferreira LC de S. Nano-multilamellar lipid vesicles loaded with a recombinant form of the chikungunya virus E2 protein improve the induction of virus-neutralizing antibodies [Internet]. Nanomedicine: Nanotechnology, Biology and Medicine. 2021 ;[citado 2024 maio 29 ] Available from: https://doi.org/10.1016/j.nano.2021.102445
Vancouver
Carvalho AAV, Favaro MT de P, Pereira LR, Jesus MJR, Pereira SS, Santos RA, Alves RP dos S, Amarante MFC, Rodrigues KB, Silva JR da, Machado RRG, Cunha M dos P, Zanotto PM de A, Fotoran WL, Wunderlich G, Durigon EL, Ferreira LC de S. Nano-multilamellar lipid vesicles loaded with a recombinant form of the chikungunya virus E2 protein improve the induction of virus-neutralizing antibodies [Internet]. Nanomedicine: Nanotechnology, Biology and Medicine. 2021 ;[citado 2024 maio 29 ] Available from: https://doi.org/10.1016/j.nano.2021.102445
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Mariângela de Oliveira et al. Antigen delivery to DEC205+ dendritic cells induces immunological memory and protective therapeutic effects against HPV-associated tumors at different anatomical sites. International Journal of Biological Sciences, v. 17, n. 11, p. 2944-2956, 2021Tradução . . Disponível em: https://doi.org/10.7150/ijbs.57038. Acesso em: 29 maio 2024.
APA
Silva, M. de O., Almeida, B. da S., Sales, N. S., Diniz, M. de O., Aps, L. R. de M. M., Rodrigues, K. B., et al. (2021). Antigen delivery to DEC205+ dendritic cells induces immunological memory and protective therapeutic effects against HPV-associated tumors at different anatomical sites. International Journal of Biological Sciences, 17( 11), 2944-2956. doi:10.7150/ijbs.57038
NLM
Silva M de O, Almeida B da S, Sales NS, Diniz M de O, Aps LR de MM, Rodrigues KB, Silva JR da, Moreno ACR, Ribeiro BFMMP, Sulczewski FB, Boscardin SB, Ferreira LC de S. Antigen delivery to DEC205+ dendritic cells induces immunological memory and protective therapeutic effects against HPV-associated tumors at different anatomical sites [Internet]. International Journal of Biological Sciences. 2021 ; 17( 11): 2944-2956.[citado 2024 maio 29 ] Available from: https://doi.org/10.7150/ijbs.57038
Vancouver
Silva M de O, Almeida B da S, Sales NS, Diniz M de O, Aps LR de MM, Rodrigues KB, Silva JR da, Moreno ACR, Ribeiro BFMMP, Sulczewski FB, Boscardin SB, Ferreira LC de S. Antigen delivery to DEC205+ dendritic cells induces immunological memory and protective therapeutic effects against HPV-associated tumors at different anatomical sites [Internet]. International Journal of Biological Sciences. 2021 ; 17( 11): 2944-2956.[citado 2024 maio 29 ] Available from: https://doi.org/10.7150/ijbs.57038
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Lennon Ramos et al. Intradermal delivery of dendritic cell-targeting chimeric mAbs genetically fused to type 2 Dengue virus nonstructural protein 1. Vaccines, v. 8, p. 19 , 2020Tradução . . Disponível em: https://doi.org/10.3390/vaccines8040565. Acesso em: 29 maio 2024.
APA
Pereira, L. R., Vicentin, E. C. M., Pereira, S. A., Maeda, D. L. N. F., Alves, R. P. dos S., Santos, R. A., et al. (2020). Intradermal delivery of dendritic cell-targeting chimeric mAbs genetically fused to type 2 Dengue virus nonstructural protein 1. Vaccines, 8, 19 . doi:10.3390/vaccines8040565
NLM
Pereira LR, Vicentin ECM, Pereira SA, Maeda DLNF, Alves RP dos S, Santos RA, Sousa FTG de, Yamamoto MM, Amarante MFC, Favaro MT de P, Romano CM, Sabino EC, Boscardin SB, Ferreira LC de S. Intradermal delivery of dendritic cell-targeting chimeric mAbs genetically fused to type 2 Dengue virus nonstructural protein 1 [Internet]. Vaccines. 2020 ; 8 19 .[citado 2024 maio 29 ] Available from: https://doi.org/10.3390/vaccines8040565
Vancouver
Pereira LR, Vicentin ECM, Pereira SA, Maeda DLNF, Alves RP dos S, Santos RA, Sousa FTG de, Yamamoto MM, Amarante MFC, Favaro MT de P, Romano CM, Sabino EC, Boscardin SB, Ferreira LC de S. Intradermal delivery of dendritic cell-targeting chimeric mAbs genetically fused to type 2 Dengue virus nonstructural protein 1 [Internet]. Vaccines. 2020 ; 8 19 .[citado 2024 maio 29 ] Available from: https://doi.org/10.3390/vaccines8040565
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JESUS, Monica Josiane Rodrigues de et al. Nano-multilemellar lipid vesicles (NMVs) enhance protective antibody responses against Shiga toxin (Stx2a) produced by enterohemorrhagic Escherichia coli strains (EHEC). Brazilian Journal of Microbiology, v. 50, p. 67-77, 2019Tradução . . Disponível em: https://doi.org/10.1007/s42770-018-0035-0. Acesso em: 29 maio 2024.
APA
Jesus, M. J. R. de, Fotoran, W. L., Cardoso, R. M., Araki, K., Wunderlich, G., & Ferreira, L. C. de S. (2019). Nano-multilemellar lipid vesicles (NMVs) enhance protective antibody responses against Shiga toxin (Stx2a) produced by enterohemorrhagic Escherichia coli strains (EHEC). Brazilian Journal of Microbiology, 50, 67-77. doi:10.1007/s42770-018-0035-0
NLM
Jesus MJR de, Fotoran WL, Cardoso RM, Araki K, Wunderlich G, Ferreira LC de S. Nano-multilemellar lipid vesicles (NMVs) enhance protective antibody responses against Shiga toxin (Stx2a) produced by enterohemorrhagic Escherichia coli strains (EHEC) [Internet]. Brazilian Journal of Microbiology. 2019 ; 50 67-77.[citado 2024 maio 29 ] Available from: https://doi.org/10.1007/s42770-018-0035-0
Vancouver
Jesus MJR de, Fotoran WL, Cardoso RM, Araki K, Wunderlich G, Ferreira LC de S. Nano-multilemellar lipid vesicles (NMVs) enhance protective antibody responses against Shiga toxin (Stx2a) produced by enterohemorrhagic Escherichia coli strains (EHEC) [Internet]. Brazilian Journal of Microbiology. 2019 ; 50 67-77.[citado 2024 maio 29 ] Available from: https://doi.org/10.1007/s42770-018-0035-0
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZANETI, Arthur Baruel et al. Dendritic cell targeting using a DNA vaccine induces specific antibodies and CD4+ T cells to the dengue virus envelope protein Domain III. Frontiers in Immunology, v. 10, p. 1-15, 2019Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2019.00059. Acesso em: 29 maio 2024.
APA
Zaneti, A. B., Yamamoto, M. M., Sulczewski, F. B., Almeida, B. da S., Souza, H. F. S., Ferreira, N. S., et al. (2019). Dendritic cell targeting using a DNA vaccine induces specific antibodies and CD4+ T cells to the dengue virus envelope protein Domain III. Frontiers in Immunology, 10, 1-15. doi:10.3389/fimmu.2019.00059
NLM
Zaneti AB, Yamamoto MM, Sulczewski FB, Almeida B da S, Souza HFS, Ferreira NS, Maeda DLNF, Sales NS, Rosa DS, Ferreira LC de S, Boscardin SB. Dendritic cell targeting using a DNA vaccine induces specific antibodies and CD4+ T cells to the dengue virus envelope protein Domain III [Internet]. Frontiers in Immunology. 2019 ; 10 1-15.[citado 2024 maio 29 ] Available from: https://doi.org/10.3389/fimmu.2019.00059
Vancouver
Zaneti AB, Yamamoto MM, Sulczewski FB, Almeida B da S, Souza HFS, Ferreira NS, Maeda DLNF, Sales NS, Rosa DS, Ferreira LC de S, Boscardin SB. Dendritic cell targeting using a DNA vaccine induces specific antibodies and CD4+ T cells to the dengue virus envelope protein Domain III [Internet]. Frontiers in Immunology. 2019 ; 10 1-15.[citado 2024 maio 29 ] Available from: https://doi.org/10.3389/fimmu.2019.00059
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARUEL ZANETI, A. et al. A DNA vaccine targeting the dengue virus envelope protein domain III to dendritic cells improves humoral and cellular immune responses. European Journal of Immunology. Weinheim: Wiley - V C H Verlag GmbH & Co. KGaA. Disponível em: https://doi.org/10.1002/eji.201871000. Acesso em: 29 maio 2024. , 2018
APA
Baruel Zaneti, A., Massao Yamamoto, M., Bandeira Sulczewski, F., da Silva Almeida, B., Santos Souza, H. F., Silva Sale , N., et al. (2018). A DNA vaccine targeting the dengue virus envelope protein domain III to dendritic cells improves humoral and cellular immune responses. European Journal of Immunology. Weinheim: Wiley - V C H Verlag GmbH & Co. KGaA. doi:10.1002/eji.201871000
NLM
Baruel Zaneti A, Massao Yamamoto M, Bandeira Sulczewski F, da Silva Almeida B, Santos Souza HF, Silva Sale N, Ferreira LC de S, Boscardin SB. A DNA vaccine targeting the dengue virus envelope protein domain III to dendritic cells improves humoral and cellular immune responses [Internet]. European Journal of Immunology. 2018 ; 48 1-193.[citado 2024 maio 29 ] Available from: https://doi.org/10.1002/eji.201871000
Vancouver
Baruel Zaneti A, Massao Yamamoto M, Bandeira Sulczewski F, da Silva Almeida B, Santos Souza HF, Silva Sale N, Ferreira LC de S, Boscardin SB. A DNA vaccine targeting the dengue virus envelope protein domain III to dendritic cells improves humoral and cellular immune responses [Internet]. European Journal of Immunology. 2018 ; 48 1-193.[citado 2024 maio 29 ] Available from: https://doi.org/10.1002/eji.201871000
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, Bruna Felício Milazzotto Maldonado Porchia et al. Herpes simplex virus glycoprotein D targets a specific dendritic cell subset and improves the performance of vaccines to human Papillomavirus-associated tumors. Molecular Cancer Therapeutics, v. 16, n. 9, p. 1922-1933, 2017Tradução . . Disponível em: https://doi.org/10.1158/1535-7163.MCT-17-0071. Acesso em: 29 maio 2024.
APA
Ribeiro, B. F. M. M. P., Moreno, A. C. R., Ramos, R. N., Diniz, M. de O. L., Andrade, L. H. T. M. de, Rosa, D. S., et al. (2017). Herpes simplex virus glycoprotein D targets a specific dendritic cell subset and improves the performance of vaccines to human Papillomavirus-associated tumors. Molecular Cancer Therapeutics, 16( 9), 1922-1933. doi:10.1158/1535-7163.MCT-17-0071
NLM
Ribeiro BFMMP, Moreno ACR, Ramos RN, Diniz M de OL, Andrade LHTM de, Rosa DS, Barbuto JAM, Boscardin SB, Ferreira LC de S. Herpes simplex virus glycoprotein D targets a specific dendritic cell subset and improves the performance of vaccines to human Papillomavirus-associated tumors [Internet]. Molecular Cancer Therapeutics. 2017 ; 16( 9): 1922-1933.[citado 2024 maio 29 ] Available from: https://doi.org/10.1158/1535-7163.MCT-17-0071
Vancouver
Ribeiro BFMMP, Moreno ACR, Ramos RN, Diniz M de OL, Andrade LHTM de, Rosa DS, Barbuto JAM, Boscardin SB, Ferreira LC de S. Herpes simplex virus glycoprotein D targets a specific dendritic cell subset and improves the performance of vaccines to human Papillomavirus-associated tumors [Internet]. Molecular Cancer Therapeutics. 2017 ; 16( 9): 1922-1933.[citado 2024 maio 29 ] Available from: https://doi.org/10.1158/1535-7163.MCT-17-0071
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANTONIALLI, Renan et al. CpG oligodeoxinucleotides and flagellin modulate the immune response to antigens targeted to CD8 alpha(+) and CD8 alpha(-) conventional dendritic cell subsets. Frontiers in Immunology, v. 8, p. 1-16 art. 1727, 2017Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2017.01727. Acesso em: 29 maio 2024.
APA
Antonialli, R., Sulczewski, F. B., Amorim, K. N. da S., Almeida, B. da S., Ferreira, N. S., Yamamoto, M. M., et al. (2017). CpG oligodeoxinucleotides and flagellin modulate the immune response to antigens targeted to CD8 alpha(+) and CD8 alpha(-) conventional dendritic cell subsets. Frontiers in Immunology, 8, 1-16 art. 1727. doi:10.3389/fimmu.2017.01727
NLM
Antonialli R, Sulczewski FB, Amorim KN da S, Almeida B da S, Ferreira NS, Yamamoto MM, Soares I da S, Ferreira LC de S, Rosa DS, Boscardin SB. CpG oligodeoxinucleotides and flagellin modulate the immune response to antigens targeted to CD8 alpha(+) and CD8 alpha(-) conventional dendritic cell subsets [Internet]. Frontiers in Immunology. 2017 ; 8 1-16 art. 1727.[citado 2024 maio 29 ] Available from: https://doi.org/10.3389/fimmu.2017.01727
Vancouver
Antonialli R, Sulczewski FB, Amorim KN da S, Almeida B da S, Ferreira NS, Yamamoto MM, Soares I da S, Ferreira LC de S, Rosa DS, Boscardin SB. CpG oligodeoxinucleotides and flagellin modulate the immune response to antigens targeted to CD8 alpha(+) and CD8 alpha(-) conventional dendritic cell subsets [Internet]. Frontiers in Immunology. 2017 ; 8 1-16 art. 1727.[citado 2024 maio 29 ] Available from: https://doi.org/10.3389/fimmu.2017.01727
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BUZZO, Carina de Lima et al. Epigenetic regulation of nitric oxide synthase 2, inducible (Nos2) by NLRC4 inflammasomes involves PARP1 cleavage. Scientific Reports, v. 7, p. 1-12, 2017Tradução . . Disponível em: https://doi.org/10.1038/srep41686. Acesso em: 29 maio 2024.
APA
Buzzo, C. de L., Medina, T., Branco, L. M., Lage, S. L., Ferreira, L. C. de S., Amarante-Mendes, J. G. P., et al. (2017). Epigenetic regulation of nitric oxide synthase 2, inducible (Nos2) by NLRC4 inflammasomes involves PARP1 cleavage. Scientific Reports, 7, 1-12. doi:10.1038/srep41686
NLM
Buzzo C de L, Medina T, Branco LM, Lage SL, Ferreira LC de S, Amarante-Mendes JGP, Hottiger MO, Carvalho DDD, Bortoluci KR. Epigenetic regulation of nitric oxide synthase 2, inducible (Nos2) by NLRC4 inflammasomes involves PARP1 cleavage [Internet]. Scientific Reports. 2017 ; 7 1-12.[citado 2024 maio 29 ] Available from: https://doi.org/10.1038/srep41686
Vancouver
Buzzo C de L, Medina T, Branco LM, Lage SL, Ferreira LC de S, Amarante-Mendes JGP, Hottiger MO, Carvalho DDD, Bortoluci KR. Epigenetic regulation of nitric oxide synthase 2, inducible (Nos2) by NLRC4 inflammasomes involves PARP1 cleavage [Internet]. Scientific Reports. 2017 ; 7 1-12.[citado 2024 maio 29 ] Available from: https://doi.org/10.1038/srep41686
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MAEDA, Denicar Lina Nascimento Fabris et al. Adjuvant-mediated epitope specificity and enhanced neutralizing activity of antibodies targeting dengue virus envelope protein. Frontiers in Immunology, v. 8, n. 1175, p. 1-13, 2017Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2017.01175. Acesso em: 29 maio 2024.
APA
Maeda, D. L. N. F., Batista, M. T., Pereira, L. R., Cintra, M. de J., Amorim, J. H., Santos, C. M. dos, et al. (2017). Adjuvant-mediated epitope specificity and enhanced neutralizing activity of antibodies targeting dengue virus envelope protein. Frontiers in Immunology, 8( 1175), 1-13. doi:10.3389/fimmu.2017.01175
NLM
Maeda DLNF, Batista MT, Pereira LR, Cintra M de J, Amorim JH, Santos CM dos, Pereira SA, Boscardin SB, Silva S dos R, Mauro EF de L, Silveira VB, Oliveira DBL, Johnston SA, Ferreira LC de S, Rodrigues JF. Adjuvant-mediated epitope specificity and enhanced neutralizing activity of antibodies targeting dengue virus envelope protein [Internet]. Frontiers in Immunology. 2017 ; 8( 1175): 1-13.[citado 2024 maio 29 ] Available from: https://doi.org/10.3389/fimmu.2017.01175
Vancouver
Maeda DLNF, Batista MT, Pereira LR, Cintra M de J, Amorim JH, Santos CM dos, Pereira SA, Boscardin SB, Silva S dos R, Mauro EF de L, Silveira VB, Oliveira DBL, Johnston SA, Ferreira LC de S, Rodrigues JF. Adjuvant-mediated epitope specificity and enhanced neutralizing activity of antibodies targeting dengue virus envelope protein [Internet]. Frontiers in Immunology. 2017 ; 8( 1175): 1-13.[citado 2024 maio 29 ] Available from: https://doi.org/10.3389/fimmu.2017.01175
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AMORIM, Jaime Henrique et al. The dengue virus non-structural 1 protein: risks and benefits. Virus Research, v. 181, p. 53-60, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.virusres.2014.01.001. Acesso em: 29 maio 2024.
APA
Amorim, J. H., Alves, R. P. dos S., Boscardin, S. B., & Ferreira, L. C. de S. (2014). The dengue virus non-structural 1 protein: risks and benefits. Virus Research, 181, 53-60. doi:10.1016/j.virusres.2014.01.001
NLM
Amorim JH, Alves RP dos S, Boscardin SB, Ferreira LC de S. The dengue virus non-structural 1 protein: risks and benefits [Internet]. Virus Research. 2014 ; 181 53-60.[citado 2024 maio 29 ] Available from: https://doi.org/10.1016/j.virusres.2014.01.001
Vancouver
Amorim JH, Alves RP dos S, Boscardin SB, Ferreira LC de S. The dengue virus non-structural 1 protein: risks and benefits [Internet]. Virus Research. 2014 ; 181 53-60.[citado 2024 maio 29 ] Available from: https://doi.org/10.1016/j.virusres.2014.01.001
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRAGA, Catarina J. M. et al. Parenteral adjuvant effects of an enterotoxigenic Escherichia coli natural heat-labile toxin variant. Frontiers in Immunology, v. 4, p. 1-11, 2014Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2013.00487. Acesso em: 29 maio 2024.
APA
Braga, C. J. M., Rodrigues, J. F., Medina-Armenteros, Y., Farinha-Arcieri, L. E., Ventura, A. M., Boscardin, S. B., et al. (2014). Parenteral adjuvant effects of an enterotoxigenic Escherichia coli natural heat-labile toxin variant. Frontiers in Immunology, 4, 1-11. doi:10.3389/fimmu.2013.00487
NLM
Braga CJM, Rodrigues JF, Medina-Armenteros Y, Farinha-Arcieri LE, Ventura AM, Boscardin SB, Sbrogio-Almeida ME, Ferreira LC de S. Parenteral adjuvant effects of an enterotoxigenic Escherichia coli natural heat-labile toxin variant [Internet]. Frontiers in Immunology. 2014 ; 4 1-11.[citado 2024 maio 29 ] Available from: https://doi.org/10.3389/fimmu.2013.00487
Vancouver
Braga CJM, Rodrigues JF, Medina-Armenteros Y, Farinha-Arcieri LE, Ventura AM, Boscardin SB, Sbrogio-Almeida ME, Ferreira LC de S. Parenteral adjuvant effects of an enterotoxigenic Escherichia coli natural heat-labile toxin variant [Internet]. Frontiers in Immunology. 2014 ; 4 1-11.[citado 2024 maio 29 ] Available from: https://doi.org/10.3389/fimmu.2013.00487
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LAGE, Silvia L. et al. Cytosolic flagellin-induced lysosomal pathway regulates inflammasome-dependent and -independent macrophage responses. Proceedings of the National Academy of Sciences of the United States of America - PNAS, v. 110, n. 35, p. E3321-3330, 2013Tradução . . Disponível em: https://doi.org/10.1073/pnas.1305316110. Acesso em: 29 maio 2024.
APA
Lage, S. L., Buzzo, C. L., Amaral, E. P., Matteucci, K. C., Massis, L. M., Icimoto, M. Y., et al. (2013). Cytosolic flagellin-induced lysosomal pathway regulates inflammasome-dependent and -independent macrophage responses. Proceedings of the National Academy of Sciences of the United States of America - PNAS, 110( 35), E3321-3330. doi:10.1073/pnas.1305316110
NLM
Lage SL, Buzzo CL, Amaral EP, Matteucci KC, Massis LM, Icimoto MY, Carmona AK, Lima MRD'I, Rodrigues MM, Ferreira LC de S, Amarante-Mendes JGP, Bortoluci KR. Cytosolic flagellin-induced lysosomal pathway regulates inflammasome-dependent and -independent macrophage responses [Internet]. Proceedings of the National Academy of Sciences of the United States of America - PNAS. 2013 ; 110( 35): E3321-3330.[citado 2024 maio 29 ] Available from: https://doi.org/10.1073/pnas.1305316110
Vancouver
Lage SL, Buzzo CL, Amaral EP, Matteucci KC, Massis LM, Icimoto MY, Carmona AK, Lima MRD'I, Rodrigues MM, Ferreira LC de S, Amarante-Mendes JGP, Bortoluci KR. Cytosolic flagellin-induced lysosomal pathway regulates inflammasome-dependent and -independent macrophage responses [Internet]. Proceedings of the National Academy of Sciences of the United States of America - PNAS. 2013 ; 110( 35): E3321-3330.[citado 2024 maio 29 ] Available from: https://doi.org/10.1073/pnas.1305316110
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HENRIQUES, Hugo R. et al. Targeting the non-structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challenge. Plos Neglected Tropical Diseases, v. 7, n. 7, p. 1-13, 2013Tradução . . Disponível em: https://doi.org/10.1371/journal.pntd.0002330. Acesso em: 29 maio 2024.
APA
Henriques, H. R., Rampazo, E. V., Gonçalves, A. J. S., Vicentin, E. C. M., Amorim, J. H., Panatieri, R. H., et al. (2013). Targeting the non-structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challenge. Plos Neglected Tropical Diseases, 7( 7), 1-13. doi:10.1371/journal.pntd.0002330
NLM
Henriques HR, Rampazo EV, Gonçalves AJS, Vicentin ECM, Amorim JH, Panatieri RH, Amorim KN da S, Yamamoto MM, Ferreira LC de S, Alves AMB, Boscardin SB. Targeting the non-structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challenge [Internet]. Plos Neglected Tropical Diseases. 2013 ; 7( 7): 1-13.[citado 2024 maio 29 ] Available from: https://doi.org/10.1371/journal.pntd.0002330
Vancouver
Henriques HR, Rampazo EV, Gonçalves AJS, Vicentin ECM, Amorim JH, Panatieri RH, Amorim KN da S, Yamamoto MM, Ferreira LC de S, Alves AMB, Boscardin SB. Targeting the non-structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challenge [Internet]. Plos Neglected Tropical Diseases. 2013 ; 7( 7): 1-13.[citado 2024 maio 29 ] Available from: https://doi.org/10.1371/journal.pntd.0002330
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AMORIM, Jaime Henrique et al. A genetic and pathologic study of a DENV2 clinical isolate capable of inducing encephalitis and hematological disturbances in immunocompetent mice. PLOS ONE, v. 7, n. 9, p. 1-12, 2012Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0044984. Acesso em: 29 maio 2024.
APA
Amorim, J. H., Bizerra, R. S. P., Alves, R. P. dos S., Sbrogio-Almeida, M. E., Levi, J. E., Capurro, M. de L., & Ferreira, L. C. de S. (2012). A genetic and pathologic study of a DENV2 clinical isolate capable of inducing encephalitis and hematological disturbances in immunocompetent mice. PLOS ONE, 7( 9), 1-12. doi:10.1371/journal.pone.0044984
NLM
Amorim JH, Bizerra RSP, Alves RP dos S, Sbrogio-Almeida ME, Levi JE, Capurro M de L, Ferreira LC de S. A genetic and pathologic study of a DENV2 clinical isolate capable of inducing encephalitis and hematological disturbances in immunocompetent mice [Internet]. PLOS ONE. 2012 ; 7( 9): 1-12.[citado 2024 maio 29 ] Available from: https://doi.org/10.1371/journal.pone.0044984
Vancouver
Amorim JH, Bizerra RSP, Alves RP dos S, Sbrogio-Almeida ME, Levi JE, Capurro M de L, Ferreira LC de S. A genetic and pathologic study of a DENV2 clinical isolate capable of inducing encephalitis and hematological disturbances in immunocompetent mice [Internet]. PLOS ONE. 2012 ; 7( 9): 1-12.[citado 2024 maio 29 ] Available from: https://doi.org/10.1371/journal.pone.0044984